Amlogenyx

Somerville, United States

Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease.

$14.0M raised

Aug 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Amlogenyx raised?

Amlogenyx has raised $14.0M in total funding. The most recent round was Seed. The last funding was announced in August 2024.

Who are Amlogenyx's investors?

Amlogenyx's investors include Ultragenyx Pharmaceutical, GordonMD Global Investments.

Where is Amlogenyx headquartered?

Amlogenyx is headquartered in Somerville, United States.

What does Amlogenyx do?

Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease.

What stage is Amlogenyx at?

Amlogenyx is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 2, 2024.

MLA

"Amlogenyx — Funding & Investors." VCBacked, August 2, 2024, https://www.vcbacked.co/company/amlogenyx. Accessed July 2, 2026.

APA

VCBacked. (2024). Amlogenyx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/amlogenyx

Wikipedia (cite web)

{{cite web |title=Amlogenyx — Funding & Investors |url=https://www.vcbacked.co/company/amlogenyx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 2, 2024.